{
    "nctId": "NCT01411787",
    "briefTitle": "Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer",
    "officialTitle": "Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer \"Can we Kick Down Ki-67, Punch Out Insulin Resistance, and Increase Survival?\"",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 11,
    "primaryOutcomeMeasure": "Ki-67 index",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Receiving neoadjuvant chemotherapy for breast cancer at one of the UT Southwestern hospitals or affiliates (Simmons Cancer Center, Parkland Hospital)\n2. No evidence of metastatic disease as confirmed by routine staging\n3. 18 - 70 year old female\n4. Karnofsky score \\>80%\n5. Body Mass Index \\>25 kg/m2\n6. Able to speak, read and understand the English language\n7. Ability to understand and willingness to sign a written informed consent document\n8. All races and ethnicities will be eligible.\n\nExclusion Criteria:\n\n1. Unable to speak, read and understand the English language\n2. Patients may not be involved in other trials evaluating the efficacy of neoadjuvant therapy\n3. Insulin-dependent diabetic patients.\n4. Known to be pregnant or planning to become pregnant during the study.\n5. Subjects are prohibited from being on other cancer treatments aside from what their treating medical oncologist has prescribed, primarily additional chemotherapies.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}